| (B) Malposition or migration of shunt/tubing (improper
positioning or later movement of shunt/tubing causing it to stop draining
adequately).
(C) Seizures (uncontrolled nerve activity).
(D) Recurrence or continuation of brain dysfunction.
(E) Injury to internal organs of the chest or abdomen.
(F) Brain injury.
(G) Stroke (damage to brain resulting in loss of one
or more functions).
(H) Persistent vegetative state (not able to communicate
or interact with others).
(I) Loss of senses (blindness, double vision, deafness,
smell, numbness, taste).
(J) Cerebrospinal fluid leak with potential for severe
headaches.
(K) Meningitis (infection of coverings of brain and
spinal cord).
(L) Need for prolonged nursing care.
(M) Need for permanent breathing tube and/or permanent
feeding tube.
(7) Elevation of depressed skull fracture.
(A) Loss of brain function such as memory and/or ability
to speak.
(B) Recurrence, continuation or worsening of the condition
that required this operation (no improvement or symptoms made worse).
(C) Loss of senses (blindness, double vision, deafness,
smell, numbness, taste).
(D) Weakness, paralysis, loss of coordination.
(E) Cerebrospinal fluid leak with potential for severe
headaches.
(F) Meningitis (infection of coverings of brain and
spinal cord).
(G) Brain abscess.
(H) Persistent vegetative state (not able to communicate
or interact with others).
(I) Seizures (uncontrolled nerve activity).
(J) Need for permanent breathing tube and/or permanent
feeding tube.
(n) Radiology.
(1) Splenoportography (needle injection of contrast
media into the spleen).
(A) All associated risks as listed under subsection
(b)(2)(B) of this section.
(B) Injury to the spleen requiring blood transfusion
and/or removal of the spleen.
(2) Chemoembolization.
(A) All associated risks as listed under subsection
(b)(2)(B) of this section.
(B) Tumor lysis syndrome (rapid death of tumor cells,
releasing their contents which can be harmful).
(C) Injury to or failure of liver (or other organ in
which tumor is located).
(D) Risks of the chemotherapeutic agent(s) utilized.
(E) Cholecystitis (inflammation of the gallbladder)
(for liver or other upper GI embolizations).
(F) Abscess (infected fluid collection) in the liver
or other embolized organ requiring further intervention.
(G) Biloma (collection of bile in or near the liver
requiring drainage) (for liver embolizations).
(3) Radioembolization.
(A) All associated risks as listed under subsection
(b)(2)(B) of this section.
(B) Tumor lysis syndrome (rapid death of tumor cells,
releasing their contents which can be harmful).
(C) Injury to or failure of liver (or other organ in
which tumor is located).
(D) Radiation complications: pneumonitis (inflammation
of lung) which is potentially fatal; inflammation of stomach, intestines,
gallbladder, pancreas; stomach or intestinal ulcer; scarring of liver.
(4) Thermal and other ablative techniques for treatment
of tumors (for curative intent or palliation) including radiofrequency
ablation, microwave ablation, cryoablation, and high intensity focused
ultrasound (HIFU).
(A) Injury to tumor-containing organ or adjacent organs/structures.
(B) Injury to nearby nerves potentially resulting in
temporary or chronic (continuing) pain and/or loss of use and/or feeling.
(C) Failure to completely treat tumor.
(5) TIPS (Transjugular Intrahepatic Portosystemic Shunt)
and its variants such as DIPS (Direct Intrahepatic Portocaval Shunt).
(A) All associated risks as listed under subsection
(b)(2)(B) - (D) of this section.
(B) Hepatic encephalopathy (confusion/decreased ability
to think).
(C) Liver failure or injury.
(D) Gallbladder injury.
(E) Hemorrhage (severe bleeding).
(F) Recurrent ascites (fluid building up in abdomen)
and/or bleeding.
(G) Kidney failure.
(H) Heart failure.
(I) Death.
(6) Myelography.
(A) Chronic (continuing) pain.
(B) Nerve injury with loss of use and/or feeling.
(C) Transient (temporary) headache, nausea, and/or
vomiting.
(D) Numbness.
(E) Seizure.
(7) Percutaneous abscess/fluid collection drainage
(percutaneous abscess/seroma/lymphocele drainage and/or sclerosis
(inclusive of percutaneous, transgluteal, transrectal and transvaginal
routes)).
(A) Sepsis (infection in the blood stream), possibly
resulting in shock (severe decrease in blood pressure).
(B) Injury to nearby organs.
(C) Hemorrhage (severe bleeding).
(D) Infection of collection which was not previously
infected, or additional infection of abscess.
(8) Procedures utilizing prolonged fluoroscopy.
(A) Skin injury (such as epilation (hair loss), burns,
or ulcers).
(B) Cataracts (for procedures in the region of the
head).
(o) Respiratory system treatments and procedures.
(1) Biopsy and/or excision of lesion of larynx, vocal
cords, trachea.
(A) Loss or change of voice.
(B) Swallowing or breathing difficulties.
(C) Perforation (hole) or fistula (connection) in esophagus
(tube from throat to stomach).
(2) Rhinoplasty or nasal reconstruction with or without
septoplasty.
(A) Deformity of skin, bone or cartilage.
(B) Creation of new problems, such as perforation of
the nasal septum (hole in wall between the right and left halves of
the nose) or breathing difficulty.
(3) Submucous resection of nasal septum or nasal septoplasty.
(A) Persistence, recurrence or worsening of the obstruction.
(B) Perforation of nasal septum (hole in wall between
the right and left halves of the nose) with dryness and crusting.
(C) External deformity of the nose.
(4) Lung biopsy.
(A) Pneumothorax (collapsed lung).
(B) Hemothorax (blood in the chest around the lung).
(5) Segmental resection of lung.
(A) Hemothorax (blood in the chest around the lung).
(B) Abscess (infected fluid collection) in chest.
(C) Insertion of tube into space between lung and chest
wall or repeat surgery.
(D) Need for additional surgery.
(6) Thoracotomy.
(A) Hemothorax (blood in the chest around the lung).
(B) Abscess (infected fluid collection) in chest.
(C) Pneumothorax (collapsed lung).
(D) Need for additional surgery.
(7) Thoracotomy with drainage.
(A) Hemothorax (blood in the chest around the lung).
(B) Abscess (infected fluid collection) in chest.
(C) Pneumothorax (collapsed lung).
(D) Need for additional surgery.
(8) Open tracheostomy.
(A) Loss of voice.
(B) Breathing difficulties.
(C) Pneumothorax (collapsed lung).
(D) Hemothorax (blood in the chest around the lung).
(E) Scarring in trachea (windpipe).
(F) Fistula (connection) between trachea into esophagus
(tube from throat to stomach) or great vessels.
(9) Respiratory tract/tracheobronchial balloon dilatation/stenting.
(A) Stent migration (stent moves from position in which
it was placed).
(B) Pneumomediastinum (air enters the space around
the airways including the space around the heart).
Cont'd... |
